Lantheus Holdings Net Cash Flow 2013-2025 | LNTH

Lantheus Holdings net cash flow from 2013 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.

Lantheus Holdings Net Cash Flow 2013-2025 | LNTH

Lantheus Holdings net cash flow from 2013 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229B
Boston Scientific (BSX)$157.6B
Stryker (SYK)$150.8B
EssilorLuxottica (ESLOY)$144B
Medtronic (MDT)$118.3B
Lonza Group Ag (LZAGY)$50.6B
Haleon (HLN)$43.2B
ResMed (RMD)$41.8B
GE HealthCare Technologies (GEHC)$33.8B
Agilent Technologies (A)$33.6B
Koninklijke Philips (PHG)$26.8B
Terumo (TRUMY)$26.5B
Insulet (PODD)$23.4B
Zimmer Biomet Holdings (ZBH)$21.3B
Smith & Nephew SNATS (SNN)$16.3B
Baxter (BAX)$12.6B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$8B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.7B
LeMaitre Vascular (LMAT)$2.2B
Acuren (TIC)$2.2B
Curaleaf Holdings (CURLF)$2.1B
QuidelOrtho (QDEL)$1.9B
Green Thumb Industries (GTBIF)$1.9B